Sg Americas Securities, LLC Crispr Therapeutics Ag Transaction History

Sg Americas Securities, LLC

  • $17.2 Billion
  • Q2 2024

A detailed history of Sg Americas Securities, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Sg Americas Securities, LLC holds 26,179 shares of CRSP stock, worth $1.17 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
26,179
Previous 38,806 32.54%
Holding current value
$1.17 Million
Previous $2.65 Million 46.54%
% of portfolio
0.01%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024
SELL
$51.17 - $68.18 $646,123 - $860,908
-12,627 Reduced 32.54%
26,179 $1.41 Million
Q1 2024

May 06, 2024
SELL
$60.67 - $89.12 $558,588 - $820,527
-9,207 Reduced 19.18%
38,806 $2.65 Million
Q4 2023

Jan 12, 2024
BUY
$38.62 - $72.18 $959,706 - $1.79 Million
24,850 Added 107.28%
48,013 $3.01 Million
Q3 2023

Oct 13, 2023
SELL
$45.39 - $59.0 $173,299 - $225,262
-3,818 Reduced 14.15%
23,163 $1.05 Million
Q2 2023

Jul 10, 2023
BUY
$43.47 - $67.77 $22,647 - $35,308
521 Added 1.97%
26,981 $1.52 Million
Q1 2023

Apr 28, 2023
SELL
$41.0 - $56.12 $35,793 - $48,992
-873 Reduced 3.19%
26,460 $1.2 Million
Q4 2022

Feb 02, 2023
BUY
$39.19 - $65.67 $567,980 - $951,755
14,493 Added 112.87%
27,333 $1.11 Million
Q3 2022

Oct 31, 2022
SELL
$61.1 - $83.78 $3.08 Million - $4.22 Million
-50,372 Reduced 79.69%
12,840 $839,000
Q2 2022

Jul 29, 2022
BUY
$43.23 - $73.83 $2.54 Million - $4.34 Million
58,765 Added 1321.45%
63,212 $3.84 Million
Q1 2022

Apr 29, 2022
SELL
$53.19 - $79.24 $994,812 - $1.48 Million
-18,703 Reduced 80.79%
4,447 $279,000
Q4 2021

Feb 07, 2022
SELL
$70.09 - $111.29 $3.42 Million - $5.43 Million
-48,806 Reduced 67.83%
23,150 $1.75 Million
Q3 2021

Nov 01, 2021
BUY
$110.2 - $156.64 $1.24 Million - $1.76 Million
11,234 Added 18.5%
71,956 $8.05 Million
Q2 2021

Aug 12, 2021
BUY
$100.84 - $161.89 $102,050 - $163,832
1,012 Added 1.69%
60,722 $9.83 Million
Q1 2021

May 13, 2021
BUY
$110.72 - $210.04 $6.02 Million - $11.4 Million
54,346 Added 1013.16%
59,710 $7.28 Million
Q4 2020

Feb 04, 2021
SELL
$79.67 - $173.23 $122,930 - $267,293
-1,543 Reduced 22.34%
5,364 $821,000
Q3 2020

Nov 09, 2020
SELL
$78.5 - $100.64 $114,924 - $147,336
-1,464 Reduced 17.49%
6,907 $578,000
Q2 2020

Jul 20, 2020
BUY
$38.5 - $76.05 $322,283 - $636,614
8,371 New
8,371 $615,000
Q1 2020

Apr 30, 2020
SELL
$33.68 - $62.53 $221,782 - $411,760
-6,585 Closed
0 $0
Q4 2019

Jan 28, 2020
SELL
$36.68 - $73.13 $437,188 - $871,636
-11,919 Reduced 64.41%
6,585 $401,000
Q3 2019

Nov 04, 2019
BUY
$40.99 - $52.56 $758,478 - $972,570
18,504 New
18,504 $758,000

Others Institutions Holding CRSP

# of Institutions
523
Shares Held
58M
Call Options Held
1.73M
Put Options Held
1.84M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.48B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email